FDA | Financial Buzz

Investing News Life Style Market News Technology The Market Buzz Your Environment

Juul Secures Financing Deal in the Midst of Massive Layoffs

Rebecca Urena11/10/2022

16776

Juul Labs revealed that it has secured financing from early investors, amid plans to lay off almost a third of its staff in a bid to avoid bankruptcy. Nevertheless,...

Market News Science Technology The Market Buzz

Veru Shares Up As Company Reports Third Quarter Financials and Progresses Sabizabulin Treatment for COVID-19

Nikita Medvedev08/11/202208/11/2022

16818

Veru Inc. (NASDAQ: VERU) shares spiked more than 30% on Thursday after the biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and Acute Respiratory Distress...

Healthcare Investing News Market News Technology The Market Buzz

FDA Grants Evoke Pharma with Market Exclusivity for GIMOTI®

David Kim04/26/2022

16871

Evoke Pharma, Inc. (NASDAQ: EVOK) has announced that the FDA has granted new drug product exclusivity for the company’s GIMOTI nasal spray. Evoke has been given exclusive marketing rights...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

Rebecca Urena03/29/202203/29/2022

17380

The Food and Drug Administration has authorized a fourth Covid vaccine dose for both Pfizer (NYSE: PFE) and Moderna (NASDAQ: PFE), for people 50 years of age and older....

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

NeuroSense Therapeutics Achieves FDA Clearance of IND for PrimeC for Treatment of ALS

David Kim03/21/2022

20102

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) has reported receipt of clearance from the United States Food and Drug Administration to begin a pharmacokinetic study of PrimeC in healthy adult subjects. ...

Tag: FDA

Juul Secures Financing Deal in the Midst of Massive Layoffs

Veru Shares Up As Company Reports Third Quarter Financials and Progresses Sabizabulin Treatment for COVID-19

FDA Grants Evoke Pharma with Market Exclusivity for GIMOTI®

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

NeuroSense Therapeutics Achieves FDA Clearance of IND for PrimeC for Treatment of ALS

ABOUT US

Tweets